BAFFR

BAFFR

BAFFR Informations sur la molécule

Molecule Name
B-cell activating factor receptor
Alias de la molécule
BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R
Drug Development Progress
Nombre de médicaments cliniques14
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéeNDA/BLA
Alias de la cible
BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
Contexte de la molécule
BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Plateforme de commerce de projets d'anticorps

Nom du projetPhase du projetType de moléculeSource de moléculeDomain thérapeutiqueIndication
BAFFR&CD3 BsAb - 01PCCBispecificHumanized Mouse,NanobodyHematological Malignancy,AutoImmunityBlood tumor,Autoimmune disease
Nom du projet
BAFFR&CD3 BsAb - 01
Phase du projet
PCC
Type de molécule
Bispecific
Source de molécule
Humanized Mouse,Nanobody
Domain thérapeutique
Hematological Malignancy,AutoImmunity
Indication
Blood tumor,Autoimmune disease